Predicting factors for depression in multiple sclerosis;Factores predictores de depresión en la esclerosis múltiple

Neurologia

Volumn 19, Issue 7, 2004, Pages 364-368

  Alarcia, R ^a,b   Ara, J R ^a   Martin J ^a   Bertol, V ^a  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b NONE   (Spain)

Author keywords

Chronic fatigue; Depression; Multiple sclerosis; Sleep disorders

Indexed keywords

BETA INTERFERON;

ANALYSIS; ARTICLE; CHRONIC FATIGUE SYNDROME; DEMOGRAPHY; DEPRESSION; DISABILITY; DISEASE DURATION; FEMALE; FREQUENCY ANALYSIS; HAMILTON SCALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIVARIATE ANALYSIS; PREDICTION; RELAPSE; RISK FACTOR; SLEEP DISORDER;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROGNOSIS;

EID: 4944258440     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Wells KB, Golding JM, Burnam MA. Psychiatric disorders in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 1988;145:976-81.
2. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
3. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907-11.
4. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
5. Kurtzke JF. A proposal for a uniform minimal record of disability in multiple sclerosis. Acta Neurol Scand 1981;64:110-29.
6. Mellerup E, Fog T, Raun N, Colville P, de Rham B, Hannah B, et al. The socio-economic scale. Acta Neurol Scand 1981;64:130-8.
7. Royuelo-Rico A, Macías-Fernández JA, Propiedades clinimétricas de la versión castellana del cuestionario de Pittsburg. Vigilia-Sueño 1997;9:81-94.
8. Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Washington (DC): Paralyzed Veterans of America, 1998.
9. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
10. Snow V, Lascher S, Mottur-Pilson C. Pharmacologic treatment of acute major depression and dysthymia. American College of Physicians American Society Internal Medicine. Ann Intern Med 2000;132:738-42.
11. Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z. Mood disorder and multiple sclerosis. Arch Neurol 1987;44:376-8.
12. Minden S, Orav J, Reich P. Depression in multiple sclerosis. Gen Hosp Psychiatry 1987;9:426-34.
13. Sadovnick AD, Remick RA, Allen J, Swartz E, Yee IML, Eisen K, et al. Depression and multiple sclerosis. Neurology 1996;46:628-32.
14. Berg D, Supprian T, Thomae J, Warmuth-Metz M, Horowski A, Zeiler B, et al. Lesion pattern in patients with multiple sclerosis and depression. Mult Scler 2000;6:156-62.
15. Sadovnick AD, Eisen K, Ebers GC, Paty DW. Cause of death in patients attending multiple sclerosis clinics. Neurology 1991;41:1193-6.
16. Fassbender K, Schmidt R, Mossner R, Kischka U, Kuhnen J, Schwartz A, et al. Mood disorders and dusfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation. Arch Neurol 1998;55:66-72.
17. Clark CM, Fleming JA, Li D, Oger J, Klonoff H, Paty D. Sleep disturbance, depression, and lesion site in patients with multiple sclerosis. Arch Neurol 1992;49:641-3.
18. Foley FW, Traugott U, LaRocca NG, Smith CR, Perlman KR, Caruso LS, et al. A prospective study of depression and immune dysregulation in multiple sclerosis. Arch Neurol 1992;49:238-44.
19. Honer WG, Hurwitz T, Li DK, Palmer M, Paty DW. Temporal lobe involvement in multiple sclerosis patients with psychiatric disorders. Arch Neurol 1987;44:187-90.
20. Bakshi R, Czarnecki D, Shaikh ZA, Priore RL, Janardhan V, Kaliszky Z, et al. Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport 2000;11:1153-8.
21. Rao SM, Reingold SC, Ron MA, Lyon-Caen O, Comi G. Workshop on neurobehavioral disorders in multiple sclerosis. Diagnosis, underlying disease, natural history, and therapeutic intervention. Bergamo, Italy June 25-27, 1992. Arch Neurol 1993;50:658-62.
22. Pujol J, Bello J, Deus J, Marti-Vilalta JL, Capdevila A. Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology 1997;49:1105-10.
23. Sabatini U, Pozilli C, Pantano P, Koudriavtseva T, Padovani A, Millefiorini E, et al. Involvement of the limbic system in multiple sclerosis patients with depressive disorders. Biol Psychiatry 1996;39:970-5.
24. Millefiorini E, Padovani A, Pozzilli C, Loriedo C, Bastianello S, Buttinelli C, et al. Depression in the early phase of MS: influence of functional disability, cognitive impairment and brain abnormalities. Acta Neurol Scand 1992;86:354-8.
25. Moller A, Wiedemann G, Rhode U, Backmund H, Sonntag A. Correlates of cognitive impairment and depressive mood in multiple sclerosis. Acta Psychiatr Scand 1994;89:117-21.
26. Rabins PV, Brooks BR, O'Donell P, Pearlson GD, Moberg P, Jubelt B, et al. Structural brain correlates of emotional disorder in multiple sclerosis. Brain 1986;109:585-97.
27. Noy S, Achiron A, Gabbay U, Barak Y, Rotstein Z, Laor N, et al. A new approach to affective symptoms in relapsing-remitting multiple sclerosis. Compr Psychiatry 1995;36:390-5.
28. Borràs C, Río J, Porcel J, Barrios M, Tintoré M, Montalban X. Emotional state of patients with relapsing-remitting MS treated with interferon beta-1b. Neurology 1999;52:1636-9.